AVNRT epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{RG}} | {{CMG}}; {{AE}} {{RG}} | ||
==Overview== | ==Overview== | ||
AVNRT is more dominant in lower age and is more related to female gender. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence | *The incidence of AVNRT is approximately 89,000 in US annually.<ref> name="Electrophysiology : the basics">{{cite book|last=Steinberg|first=Jonathan|title=Electrophysiology : the basics|publisher=Wolters Kluwer Heath|location=Philadelphia|year=2017|isbn=9781496340016}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The | *The prevalence of AVNRT is approximately 570,000 per US population | ||
===Age=== | ===Age=== | ||
* | *Mean age of symptom onset is 32 ± 18 years.<ref name="QuattrocelliLang2018">{{cite journal|last1=Quattrocelli|first1=Amanda|last2=Lang|first2=Janet|last3=Davis|first3=Andrew|last4=Pflaumer|first4=Andreas|title=Age makes a difference: Symptoms in pediatric supraventricular tachycardia|journal=Journal of Arrhythmia|volume=34|issue=5|year=2018|pages=565–571|issn=1880-4276|doi=10.1002/joa3.12103}}</ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to AVNRT. | ||
===Gender=== | ===Gender=== | ||
* | *AVNRT affects women more than men.<ref name="GhaniMaas2010">{{cite journal|last1=Ghani|first1=A.|last2=Maas|first2=A. H. E. M.|last3=Delnoy|first3=P. P. H. M.|last4=Ramdat Misier|first4=A. R.|last5=Ottervanger|first5=J. P.|last6=Elvan|first6=A.|title=Sex-Based Differences in Cardiac Arrhythmias, ICD Utilisation and Cardiac Resynchronisation Therapy|journal=Netherlands Heart Journal|volume=19|issue=1|year=2010|pages=35–40|issn=1568-5888|doi=10.1007/s12471-010-0050-8}}</ref> | ||
===Region=== | ===Region=== | ||
*The | *The prevalence of AVNRT globally is similar to the united states. | ||
*There is insufficient evidence suggesting a region being more vulnerable to disease. | |||
* | |||
==References== | ==References== | ||
Latest revision as of 00:13, 20 July 2020
|
AVNRT Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
AVNRT epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of AVNRT epidemiology and demographics |
|
Risk calculators and risk factors for AVNRT epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
AVNRT is more dominant in lower age and is more related to female gender.
Epidemiology and Demographics
Incidence
- The incidence of AVNRT is approximately 89,000 in US annually.[1]
Prevalence
- The prevalence of AVNRT is approximately 570,000 per US population
Age
- Mean age of symptom onset is 32 ± 18 years.[2]
Race
- There is no racial predilection to AVNRT.
Gender
- AVNRT affects women more than men.[3]
Region
- The prevalence of AVNRT globally is similar to the united states.
- There is insufficient evidence suggesting a region being more vulnerable to disease.
References
- ↑ name="Electrophysiology : the basics">Steinberg, Jonathan (2017). Electrophysiology : the basics. Philadelphia: Wolters Kluwer Heath. ISBN 9781496340016.
- ↑ Quattrocelli, Amanda; Lang, Janet; Davis, Andrew; Pflaumer, Andreas (2018). "Age makes a difference: Symptoms in pediatric supraventricular tachycardia". Journal of Arrhythmia. 34 (5): 565–571. doi:10.1002/joa3.12103. ISSN 1880-4276.
- ↑ Ghani, A.; Maas, A. H. E. M.; Delnoy, P. P. H. M.; Ramdat Misier, A. R.; Ottervanger, J. P.; Elvan, A. (2010). "Sex-Based Differences in Cardiac Arrhythmias, ICD Utilisation and Cardiac Resynchronisation Therapy". Netherlands Heart Journal. 19 (1): 35–40. doi:10.1007/s12471-010-0050-8. ISSN 1568-5888.